These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30259646)

  • 61. Myeloablative unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: comparison with other graft sources from related and unrelated donors.
    Konuma T; Kato S; Ooi J; Oiwa-Monna M; Tojo A; Takahashi S
    Ann Hematol; 2015 Feb; 94(2):289-96. PubMed ID: 25178518
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Unrelated donor hematopoietic stem cell transplantation for infantile enteropathy due to IL-10/IL-10 receptor defect.
    Gassas A; Courtney S; Armstrong C; Kapllani E; Muise AM; Schechter T
    Pediatr Transplant; 2015 Jun; 19(4):E101-3. PubMed ID: 25761563
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Giebel S; Labopin M; Socié G; Beelen D; Browne P; Volin L; Kyrcz-Krzemien S; Yakoub-Agha I; Aljurf M; Wu D; Michallet M; Arnold R; Mohty M; Nagler A
    Haematologica; 2017 Jan; 102(1):139-149. PubMed ID: 27686376
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
    Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inherited aplastic anaemias/bone marrow failure syndromes.
    Dokal I; Vulliamy T
    Blood Rev; 2008 May; 22(3):141-53. PubMed ID: 18164793
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.
    Worel N; Buser A; Greinix HT; Hägglund H; Navarro W; Pulsipher MA; Nicoloso de Faveri G; Bengtsson M; Billen A; Espino G; Fechter M; Giudice V; Hölig K; Kanamori H; Kodera Y; Leitner G; Netelenbos T; Niederwieser D; van Walraven SM; Rocha V; Torosian T; Vergueiro C; Weisdorf D; Yabe H; Halter JP
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2052-2060. PubMed ID: 26271194
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hematopoietic stem cell transplantation for sickle cell disease: state of the science.
    Talano JA; Cairo MS
    Eur J Haematol; 2015 May; 94(5):391-9. PubMed ID: 25200500
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.
    Bouvier A; Ribourtout B; François S; Orvain C; Paz DL; Beucher A; Guérard A; Guardiola P; Ugo V; Blanchet O; Geneviève F; Schmidt A; Hunault-Berger M
    Eur J Haematol; 2018 Oct; 101(4):570-574. PubMed ID: 30007088
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Outcomes of alternative donor allogeneic hematopoietic stem cell transplantation for Fanconi anemia: a five cases report].
    Wang WJ; Sun YQ; Tang FF; Han TT; Mo XD; Wang JZ; Zhang XH; Huang XJ; Xu LP
    Zhonghua Nei Ke Za Zhi; 2018 Jan; 57(1):54-56. PubMed ID: 29325312
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning Is Successful in Children with Hematologic Cytopenias of Genetic Origin.
    Kothari A; Ngwube A; Hayashi R; Murray L; Davis J; Haut P; Loechelt BJ; Shenoy S
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1321-5. PubMed ID: 25840334
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunological properties of bone marrow microenvironment 1 year after allogeneic hematopoietic stem cell transplantation.
    Ciomber A; Mitrus I; Fidyk W; Smagur A; Chwieduk A; Glowala-Kosinska M; Czerw T; Sobczyk-Kruszelnicka M; Mendrek W; Sadus-Wojciechowska M; Najda J; Holowiecki J; Giebel S
    Exp Hematol; 2016 Dec; 44(12):1172-1180.e1. PubMed ID: 27524270
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Allogeneic transplantation for aplastic anemia.
    Eapen M
    Hematology; 2012 Apr; 17 Suppl 1():S15-7. PubMed ID: 22507769
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical features of dyskeratosis congenita in mainland China: case reports and literature review.
    Li F; Li W; Qiao X; Xie X
    Int J Hematol; 2019 Mar; 109(3):328-335. PubMed ID: 30604317
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
    J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Addressing Ethical and Procedural Principles for Unrelated Allogeneic Hematopoietic Progenitor Cell Donation in a Changing Medical Environment.
    van Walraven SM; Egeland T; Borrill V; Nicoloso-de Faveri G; Rall G; Szer J;
    Biol Blood Marrow Transplant; 2018 May; 24(5):887-894. PubMed ID: 29410372
    [No Abstract]   [Full Text] [Related]  

  • 78. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Fludarabine-based increased-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia].
    Sun C; Lin X; Huang Y; Song C; Tao Y; Tu S; Fang J; Chen T; Sun C; Wu B
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):221-4. PubMed ID: 24666488
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TCR αβ and CD19-depleted haploidentical stem cell transplant with reduced intensity conditioning for Hoyeraal-Hreidarsson syndrome with RTEL1 mutation.
    Bhattacharyya R; Tan AM; Chan MY; Jamuar SS; Foo R; Iyer P
    Bone Marrow Transplant; 2016 May; 51(5):753-4. PubMed ID: 26808564
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.